Clinical Trials

1,300 enrolled

Fibrosis, Carcinoma, Hepatocellular

NCT07053813 2026-02-27

CARE-HCS

900 enrolled

Neoplastic Syndromes, Hereditary

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

GastrointestinalGenitourinary

100 enrolled

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

120 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07400835 2026-02-24

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

600 enrolled

Gynecologic

Endometrial Neoplasms

NCT07429760 2026-02-24

Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery

60 enrolled

Colorectal Neoplasms

NCT07422727 2026-02-20

COOLVAS

40 enrolled

Neoplasms, Hot Flashes

NCT06388252 2026-02-19

Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients

10 enrolled

Dermatologic

Melanoma, Cutaneous Malignant

NCT06412029 2026-02-19

HRSN

144 enrolled

Tumor-Agnostic

Neoplasms

NCT04693754 2026-02-18

EUS-RFA

100 enrolled

Pancreatic Neoplasms

NCT01382082 2026-02-17

CANTAB

1,432 enrolled

BreastLymphoid

Breast Neoplasms, Lymphoma

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

5,000 enrolled

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT06184594 2026-02-17

Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening

400 enrolled

Colorectal Neoplasms

NCT06822530 2026-02-17

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

682 enrolled

Colorectal Neoplasms

NCT04996316 2026-02-13

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

1,141 enrolled

Breast

Breast Neoplasms

NCT07409298 2026-02-13

Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy

300 enrolled

Breast

Breast Neoplasms

NCT07410403 2026-02-13

AI

10 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT05879211 2026-02-12

Goal Concordant Care Learning Laboratory

5,000 enrolled

Dementia, Heart Failure, Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT06730685 2026-02-12

PHILUCA

160 enrolled

Thoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma, Sarcopenia

NCT07225920 2026-02-12

PGA

216 enrolled

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT07274579 2026-02-10

An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma

Phase 2 Enrolling by invitation

2,000 enrolled

Digestive Oncology

NCT06250777 2026-02-09

ELPIS

27 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06332131 2026-02-09

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

25 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cardiotoxicity

NCT07390565 2026-02-09

YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

308 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07395505 2026-02-09

PROS-PE

24 enrolled

Phase 2 Enrolling by invitation

Rectal Neoplasms

NCT07386704 2026-02-04

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

30 enrolled

Pancreatic Cancer Non-resectable

NCT07348549 2026-02-03

Gagne Learning Model in Nursing Education

68 enrolled

Nursing Education

NCT07383298 2026-02-03

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

MyeloidOther hematologic neoplasm

100 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07384741 2026-02-03

VR-PICCPORT

120 enrolled

Anxiety Disorders, Pain, Personal Satisfaction

NCT07381985 2026-02-02

LINC

200 enrolled

Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary

NCT04254133 2026-01-30

GIFTS